Muscle-derived stem cells: Potential for muscle regeneration

Birth Defects Research Part C - Embryo Today: Reviews

Volumn 69, Issue 3, 2003, Pages 230-237

  Huard, Johnny ^a   Cao, Baohong ^a   Qu Petersen, Zhuqing ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; CD34 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; DESMIN; DYSTROPHIN; MEMBRANE PROTEIN; MYOD PROTEIN; MYOGENIN; PROTEIN BCL 2; RECEPTOR; STEM CELL FACTOR;

ADOPTIVE IMMUNOTHERAPY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL RENEWAL; CELL TRANSPLANTATION; DUCHENNE MUSCULAR DYSTROPHY; GENE THERAPY; GENE TRANSFER; HOMEOSTASIS; HUMAN; LONG TERM POTENTIATION; MESENCHYME; MUSCLE REGENERATION; MUSCLE WEAKNESS; MYOBLAST; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SKELETAL MUSCLE; STEM CELL;

ANIMALS; CELL DIFFERENTIATION; CELL TRANSPLANTATION; CELLS, CULTURED; DYSTROPHIN; GENE THERAPY; HUMANS; MODELS, BIOLOGICAL; MUSCLE, SKELETAL; MUSCLES; MUSCULAR DYSTROPHY, DUCHENNE; REGENERATION; STEM CELLS; TISSUE THERAPY;

EID: 0141890192     PISSN: 1542975X     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdrc.10020     Document Type: Review

References (86)

1. Andrews RG, Singer W, Bernstein ID. 1986. Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood 67:842-845.
2. Arahata K, Ishiura S, Ishiguro T, et al. 1988. Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide. Nature 333:861-863.
3. Baroffio A, Hamann M, Bernheim L, et al. 1996. Identification of self-renewing myoblasts in the progeny of single human muscle satellite cells. Differentiation 60:47-57.
4. Beauchamp JR, Morgan JE, Pagel CN, Partridge TA. 1994. Quantitative studies of the efficacy of myoblast transplantation. Muscle Nerve 18(suppl):S261.
5. Beauchamp JR, Morgan JE, Pagel CN, Partridge TA. 1999. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J Cell Biol 144:1113-1122.
6. Beauchamp JR, Heslop L, Yu DSW, et al. 2000. Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells. J Cell Biol 151:1221-1233.
7. Bittner RE, Schofer C, Weipoltshammer K, et al. 1999. Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat Embryol 199:391-396.
8. Blau HM, Brazelton TR, Weimann JM. 2001. The evolving concept of a stem cell: entity of function? Cell 105:829-841.
9. Bonilla ECE, Samitt CE, Miranda AF, et al. 1988. Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface. Cell 54:447-452.
10. Bosch P, Musgrave DS, Lee JY, et al. 2000. Osteoprogenitor cells within skeletal muscle. J Orthop Res 18:933-944.
11. Cao B, Zheng B, Jankowski RJ, et al. 2003. Muscle stem cells differentiate into hematopoietic lineages but retain myogenic potential. Nat Cell Biol 5:640-646.
12. Caplan AI. 1991. Mesenchymal stem cells. J Orthop Res 9:641-650.
13. Civin CI, Strauss LC, Brovall C, et al. 1984. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 133:157-165.
14. Clark DL, Johansson CB, Wilbertz J, et al. 2000. Generalized potential of adult neural stem cells. Science 288:1660-1663.
15. Cornelison DD, Wold BJ. 1997. Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. Dev Biol 191:270-283.
16. DeAngelis L, Berghella L, Coletta M, et al. 1999. Skeletal myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration. J Cell Biol 147:869-878.
17. Dominov JA, Dunn JJ, Miller JB. 1998. Bcl-2 expression identifies an early stage of myogenesis and promotes clonal expansion of muscle cells. J Cell Biol 142:537-544.
18. Ervasti JM, Campbell KP. 1991. Membrane organization of the dystrophinglycoprotein complex. Cell 66:1121-1131.
19. Fan Y, Maley M, Beilharz M, Grounds M. 1996. Rapid death of injected myoblasts in myoblast transfer therapy. Muscle Nerve 19:853-860.
20. Ferrari G, Cusella-DeAngelis G, Coletta M, et al. 1998. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279:1528-1530.
21. Fina L, Molgaard HV, Robertson D, et al. 1990. Expression of the CD34 gene in vascular endothelial cells. Blood 75:2417-2426.
22. Galli R, Borello U, Gritti A, et al. 2000. Skeletal myogenic potential of human and mouse neural stem cells. Nat Neurosci 3:986-991.
23. Goodell MA. 1999. CD34(+) or CD34(-): does it really matter? Blood 94:2545-2547.
24. Goodell MA, Jackson KA, Majka SM, et al. 2001. Stem cell plasticity in muscle and bone marrow. Ann N Y Acad Sci 938:208-218.
25. Guerette B, Asselin I, Skuk D, et al. 1997. Control of inflammatory damage by anti-LFA-1: increase success of myoblast transplantation. Cell Transplant 6:101-107.
26. Gussoni E, Pavlath GK, Lanctot AM, et al. 1992. Normal dystrophin transcripts detected in DMD patients after myoblast transplantation. Nature 356:435-438.
27. Gussoni E, Blau HM, Kunkel LM. 1997. The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat Med 3:970-977.
28. Gussoni E, Soneoka Y, Strickland CD, et al. 1999. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401:390-394.
29. Ham R, Veomett M. 1980. Mechanisms of development. St. Louis: C.V. Mosby Company. p 5-107.
30. Hoffman EP, Brown J, Kunkel LM. 1987. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51:919-928.
31. Huard J, Bouchard JP, Roy R, et al. 1991. Myoblast transplantation produced dystrophin-positive muscle fibers in a 16-year-old patient with Duchenne muscular dystrophy. Clin Sci 81:287-288.
32. Huard J, Bouchard JP, Roy R, et al. 1992a. Human myoblast transplantation: preliminary results of 4 cases. Muscle Nerve 15:550-560.
33. Huard J, Roy R, Bouchard JP, et al. 1992b. Human myoblast transplantation between immunohistocompatible donors and recipients produces immune reactions. Transplant Proc 24:3049-3051.
34. Huard J, Roy R, Guerette B, et al. 1994a. Human myoblast transplantation in immunodeficient and immunosuppressed mice: evidence of rejection. Muscle Nerve 17:224-234.
35. Huard J, Verreault S, Roy R, et al. 1994b. High efficiency of muscle regeneration following human myoblast clone transplantation in SCID mice. J Clin Invest 93:586-599.
36. Huard J, Acsadi G, Massie B, Karpati G. 1994c. Gene transfer into skeletal muscles by isogenic myoblasts. Hum Gene Ther 5:949-958.
37. Ibraghinov-Beskrovnaya O, Ervasti JM, Leveille CJ, et al. 1992. Primary structure of dystrophin-associated proteins linking dystrophin to the extracellular matrix. Nature 355:696-702.
38. Irintchev A, Zeschnigk M, Starzinski-Powitz A, Wernig A. 1994. Expression pattern of m-cadherin in normal, denervated, and regenerating mouse muscle. Dev Dyn 199:326-337.
39. Jackson KA, Mi T, Goodell MA. 1999. Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc Natl Acad Sci U S A 96:14482-14486.
40. Jankowski RJ, Deasy B, Cao B, et al. 2002. The role of CD34 expression and cellular fusion in the regenerative capacity of myogenic progenitor cells. J Cell Sci 115:4361-4374.
41. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. 2002a. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49.
42. Jiang Y, Vaessen B, Lenvik T, et al. 2002b. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle and brain. Exp Hematol 30:896-904.
43. Karpati G, Pouliot Y, Zubrzycka-Gaarn E, et al. 1989. Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation. Am J Pathol 135:27-32.
44. Karpati G, Worton RG. 1992. Myoblast transfer in DMD: problems in the interpretation of efficiency. Muscle Nerve 15:1209-1210.
45. Katagiri T, Yamaguchi A, Komaki M, et al. 1994. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127:1755-1766.
46. Kawada H, Ogawa M. 2001a. Bone marrow origin of hematopoietic and stem cellsin murine muscle. Blood 98:2008-2013.
47. Kawada H, Ogawa M. 2001b. Hematopoietic progenitors and stem cells in murine muscle. Blood Cells Mol Dis 27:605-609.
48. Kinoshita I, Vilquin JT, Guerette B, et al. 1994. Very efficient myoblast allo-transplantation in mice under FKS06 immunosuppression. Muscle Nerve 17:1407-1415.
49. Lee JY, Qu-Petersen Z, Cao B, et al. 2000. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol 150:1085-1099.
50. McKinney-Freeman SL, Jackson KA, Camargo FD, et al. 2002. Muscle-derived hematopoietic stem cells are hematopoietic in origin. Proc Natl Acad Sci U S A 99:1341-1346.
51. Mendell JR, Kissel JT, Amato AA, et al. 1995. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. New Engl J Med 333:832-838.
52. Miller JB, Schaefer L, Dominov JA. 1999. Seeking muscle stem cells. Curr Top Dev Biol 43:191-219.
53. Morgan JE, Watt DJ, Slopper JC, Partridge TA. 1988. Partial correction of an inherited defect of skeletal muscle by graft of normal muscle precursor cells. J Neurol Sci 86:137-147.
54. Morgan JE, Hoffman EP, Partridge TA. 1990. Normal myogenic cells from newborn mice restore normal histology to degenerating muscle of the mdx mouse. J Cell Biol 111:2437-2449.
55. Morgan JE, Pagel CN, Sherratt T, Partridge TA. 1993. Long-term persistence and migration of myogenic cells injected into pre-irradiated muscle of mdx mice. J Neurol Sci 115:191-200.
56. Ogawa M, Matsuzaki Y, Nishikawa S, et al. 1991. Expression and function of c-kit in hemapoietic progenitor cells. J Exp Med 174:63-71.
57. Okada S, Nakauchi H, Nagayoshi K, et al. 1991. Enrichment and characterization of murine hematopoietic stem cells that express c-kit molecule. Blood 78:1706-1712.
58. Okada S, Nakauchi H, Nagayoshi K, et al. 1992. In vivo and in vitro stem cell function of c-kit- and Sca-1-positive murine hematopoietic cells. Blood 80:3044-3050.
59. Osawa M, Hanada K, Hamada H, Nakauchi H. 1996. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273:242-452.
60. Partridge TA. 1991. Myoblast transfer: a possible therapy for inherited myopathies. Muscle Nerve 14:197-212.
61. Peng H, Wright V, Usas A, et al. 2002. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. Clin Invest 110:751-759.
62. Pittenger MF, MacKay AM, Beck SC, et al. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
63. Qu Z, Balkir L, van Deutekom JC, et al. 1998. Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol 142:1257-1267.
64. Qu Z, Huard J. 2000a. Matching host muscle and donor myoblasts for myosin heavy chain improves myoblast transfer therapy. Gene Ther 7:428-437.
65. Qu Z, Huard J. 2000b. The influence of muscle fiber type in myoblast-mediated gene transfer to skeletal muscle. Cell Transplant 9:503-517.
66. Qu-Petersen Z, Deasy B, Jankowski RI, et al. 2002. Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J Cell Biol 157:851-864.
67. Rasko JE, Metcalf D, Rossner MT, et al. 1995. The flt3/flk-2 ligand: receptor distribution and action on murine haemopoietic cell survival and proliferation. Leukemia 9:2058-2066.
68. Reyes M, Lund T, Todd L, et al. 2001. Purification and ex vivo expansion of post-natal marrow mesodermal progenitor cells. Blood 98:2615-2625.
69. Reyes M, Dudek A, Jahagirdar B, et al. 2002. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 109:337-346.
70. Rietze RL, Valcanis H, Brooker GF, et al. 2001. Purification of a pluripotential neural stem cell from the adult mouse brain. Nature 412:736-739.
71. Sato T, Laver JH, Ogawa M. 1999. Reversible expression of CD34 by murine hematopoietic stem cells. Blood 94:2548-2554.
72. Schwartz RE, Reyes M, Koodie L, et al. 2002. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest 109:1291-1302.
73. Seale P, Sabourin LA, Girgis-Gabardo A, et al. 2000. Pax7 is required for the specification of myogenic satellite cells. Cell 102:777-786.
74. Simmons PJ, Torok-Storb B. 1991. CD34 expression by stromal precursors in normal human adult bone marrow. Blood 78:2848-2853.
75. Spangrude GJ, Heimfeld S, Weissman IL. 1988. Purification and characterization of mouse hematopoietic stem cells. Science 241:58-62.
76. Torrente Y, Trembray JP, Pisati F, et al. 2001. Intraarterial injection of muscle-derived CD34(+)Sca-l(+) stem cells restores dystrophin in mdx mice. J Cell Biol 152:335-348.
77. Tremblay JP, Malouin F, Roy R, et al. 1993. Results of a blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant 2:99-112.
78. Uchida N, Weissman TL. 1992. Searching for hematopoietic stem cells: evidence that THY-1.11 Sca-1+ cells sare the only stem cells in C57BL/Ka-Thy-1. 1 bone marrow. J Exp Med 175:175-184.
79. Vilquin JT, Wagner E, Kinoshita I, et al. 1995. Successful histocompatible myoblast transplantation in dystrophin-deficient mdx mouse despite the production of antibodies against dystrophin. J Cell Biol 131:975-988.
80. Young HE, Ceballos EM, Smith JC, et al. 1993. Pluripotent mesenchymal stem cells reside within avian connective tissue matrices. In Vitro Cell Dev Biol Anim 29A:723-736.
81. Young HE, Mancini ML, Wright RP, et al. 1995. Mesenchymal stem cells reside within the connective tissues of many organs. Dev Dyn 202:137-144.
82. Young HE, Steele TA, Bray RA, et al. 2001. Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult and geriatric donors. Anat Rec 264:51-62.
83. Zammit P, Beauchamp J. 2001. The skeletal muscle satellite cells: stem cell or son of stem cell? Differentiation 68:193-204.
84. Ziegler BL, Valtieri M, Porada GA, et al. 1999. KDR receptor: a key marker defining hematopoietic stem cells. Science 285:1553-1558.
85. Zubryzcka-Gaarn EE, Bulman DE, Karpati G, et al. 1988. The Duchenne muscular dystrophy gene is localized in the sarcolemma of human skeletal muscle. Nature 333:466-469.
86. Zuk PA, Zhu M, Mizuno H, et al. 2001. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7:211-228.